C2 C Wealth Management, LLC Moderna, Inc. Transaction History

C2 C Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$96.41 - $126.61 $665,132 - $873,482	-6,899 Reduced 55.55%	5,520 $570,000
Q2 2023 Jul 20, 2023	SELL	$118.5 - $160.53 $374,223 - $506,953	-3,158 Reduced 20.27%	12,419 $1.51 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $619,559 - $899,790	4,567 Added 41.48%	15,577 $2.39 Million
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $51,021 - $90,527	-431 Reduced 3.77%	11,010 $1.98 Million
Q3 2022 Oct 12, 2022	SELL	$118.07 - $194.18 $35,421 - $58,254	-300 Reduced 2.56%	11,441 $1.44 Million
Q2 2022 Jul 22, 2022	BUY	$117.13 - $176.59 $210,834 - $317,862	1,800 Added 18.11%	11,741 $1.96 Million
Q1 2022 Apr 29, 2022	SELL	$126.46 - $235.05 $286,431 - $532,388	-2,265 Reduced 18.56%	9,941 $1.49 Million
Q4 2021 Feb 23, 2022	BUY	$225.82 - $368.51 $2.76 Million - $4.5 Million	12,206 New	12,206 $3.1 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on C2 C Wealth Management, LLC with notifications on news.